ZEVTERA

This brand name is authorized in Austria, Canada, Ecuador, Spain, Finland, Poland, United Kingdom

Active ingredients

The drug ZEVTERA contains one active pharmaceutical ingredient (API):

1 Ceftobiprole medocaril UNII N99027V28J - CEFTOBIPROLE MEDOCARIL

Ceftobiprole exerts bactericidal activity through binding to important penicillin-binding proteins (PBPs) in susceptible species. Read about Ceftobiprole medocaril

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZEVTERA Powder for concentrate for solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DI01	Ceftobiprole medocaril	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DI Other cephalosporins
Discover more medicines within J01DI01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02446685
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5083-MEE-0420
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 78691
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 461122
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 310137
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100385920